Newomics

Newomics Inc. is an early-stage biotechnology company located in the San Francisco Bay Area, dedicated to commercializing innovative and integrated (Omics) platforms as well as solutions for personalized medicine. Our proprietary technology is based on silicon microfluidic chips for liquid chromatography-mass spectrometry (LC-MS), providing unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules in trace biological samples such as blood and urine. Our core technology is based on the multi-nozzle emitter array (MEA) technology invented at Lawrence Berkeley National Laboratory (Berkeley Lab), which won the 2012 R&D 100 Award.